| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |